SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-034699
Filing Date
2020-06-05
Accepted
2020-06-05 16:37:57
Documents
2
Period of Report
2020-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3448
2 POA DOCUMENT poa.txt EX-24.4_920314 3330
  Complete submission text file 0001209191-20-034699.txt   8158
Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
OLANOFF LAWRENCE S (Reporting) CIK: 0001224341 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34620 | Film No.: 20946829

Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Issuer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations